any thoughts on the numbers?? thanks
Outlook Therapeutics GAAP EPS of -$0.09 misses by $0.03
May 13, 2022 8:06 AM ETOutlook Therapeutics, Inc. (OTLK)By: Deepa Sarvaiya, SA News Editor
Outlook Therapeutics press release (NASDAQ:OTLK): Q2 GAAP EPS of -$0.09 misses by $0.03.
At March 31, 2022, Outlook Therapeutics had cash and cash equivalents of $58.4 million, compared to $70.2 million at December 31, 2021.